Day: November 10, 2019

Niðurstöður um kaup á eigin hlutum með tilboðs fyrirkomulagiStjórn Festi hf. ákvað að taka tilboðum fyrir kr. 1.000.000 að nafnverði á genginu 130,95 í endurkaupum sem tilkynnt var um fimmtudaginn 7. nóvember 2019Uppgjörsdagur verður 15. nóvember 2019.Festi birti árshlutauppgjör þriðja ársfjórðungs 2019 þann 6. nóvember 2019.Endurkaupin eru framkvæmd í samræmi við lög um hlutafélög nr. 2/1995 og lög um verðbréfaviðskipti nr. 103/2007.Nánari upplýsingar veitirEggert Þór Kristófersson, forstjórieggert@festi.is

SURREY, British Columbia, Nov. 10, 2019 (GLOBE NEWSWIRE) — CN (TSX: CNR) (NYSE: CNI) is proud to announce today that the last known Centurion tank in Canada to be on the front lines during the Korean War arrived in British Columbia on Sunday, after a journey on CN’s network from Nova Scotia. The Centurion was loaded onto a rail car at the CN Yard in Dartmouth, NS on October 30 and arrived in Surrey, BC on Sunday morning. A.W. Liel, John Hunter Trucking Co., Total Transport & Rigging, Quiring Towing and Recovery, as well as Lumpy’s Lowbed Service all helped complete the coast-to-coast transfer.Township of Langley Councillor Bob Long, and retired Major Ian Davidson Newby from the Western Museum of Armed Forces in Langley, reached out earlier this year to CN to help bring the tank to British Columbia. Through close collaboration...

SURREY, Colombie-Britannique, 10 nov. 2019 (GLOBE NEWSWIRE) — Le CN (TSX : CNR) (NYSE : CNI) est fier d’annoncer que le dernier char d’assaut Centurion au Canada à avoir été au front durant la guerre de Corée est arrivé en Colombie-Britannique dimanche, après un périple sur le réseau du CN au départ de Nouvelle-Écosse. Le char Centurion a été chargé sur un wagon au triage du CN à Dartmouth, N.-É., le 30 octobre et est arrivé à Surrey, C.-B., dimanche matin. A.W. Liel, John Hunter Trucking Co., Total Transport & Rigging, Quiring Towing and Recovery, de même que Lumpy’s Lowbed Service, ont participé au transport d’un océan à l’autre de cette pièce de l’histoire militaire canadienne.Le conseiller du canton de Langley, Bob Long, et le major à la retraite du Western Museum of the Armed Forces à Langley, M. Ian Davidson Newby, ont...

CALGARY, Alberta, Nov. 10, 2019 (GLOBE NEWSWIRE) — Media Advisory — TC Energy Corporation (TSX:TRP) (NYSE:TRP) (TC Energy) today announced that its Keystone pipeline has returned to service following the approval of its repair and restart plan by the U.S. Pipeline and Hazardous Materials Safety Administration (PHMSA).As part of the restart plan, TC Energy will operate the pipeline at a reduced pressure with a gradual increase in the volume of crude oil moving through the system. We are communicating plans to our customers and will continue working closely with them as we begin to return to normal operating conditions.We appreciate the cooperation and support from local officials, emergency response personnel and commissioners in Walsh County, as well as the landowner who has granted permission to access land for assessment,...

Meðfylgjandi er tilkynning vegna viðskipta fjárhagslega tengds aðila.ViðhengiTilkynning – viðskipti fjárhagslega tengds aðila – Heimavellir hf. – Frostaskjól

MONTREAL and SARASOTA, Fla., Nov. 10, 2019 (GLOBE NEWSWIRE) — Intertape Polymer Group Inc. (TSX:ITP)AN ACCOMPANYING PRESENTATION WILL ALSO BE AVAILABLE.  DETAILS FOR ACCESS WILL BE INCLUDED IN THE THIRD QUARTER PRESS RELEASE.CONFERENCE CALL WILL BE AVAILABLE BY WEBCASTClick on following link to pre-registerhttps://event.on24.com/wcc/r/2122868-1/B45D561034994DDB03D869CABC7248AA THIRD QUARTER RESULTS WILL BE PUBLISHED BEFOREMARKET OPENS, NOVEMBER 11, THROUGH GLOBENEWSWIRE.For further information, please contact:Ross MarshallLodeRock Advisors, Inc.Tel : (416) 526-1563

GENFIT Announces Results of NIS4, an Investigational Non-Invasive NASH Diagnostic, at AASLD 2019NIS4 is GENFIT’s innovative non-invasive in vitro diagnostic test, or IVD, to identify patients with NASH who may be appropriate candidates for drug therapyProgram is based on the in-house discovery of a 4-biomarker algorithm potentially replacing biopsy with a single blood testStudy finds patients living with type 2 diabetes are at increased risk of being diagnosed with NASH                   Lille (France), Cambridge (Massachusetts, United States), November 10, 2019 – GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to the discovery and development of innovative therapeutic and diagnostic solutions in metabolic and liver related diseases, today announced results from a study demonstrating NIS4, an innovative...

GENFIT : Résultats d’une étude avec NIS4, outil de diagnostic expérimental non invasif de la NASH, présentés à l’AASLD 2019NIS4 est le test de diagnostic in-vitro (IVD) novateur et non-invasif développé par GENFIT pour identifier les patients NASH potentiellement éligibles à un traitement médicamenteuxLe programme s’appuie sur la découverte en interne d’un algorithme à 4 variables permettant potentiellement de remplacer la biopsie par un seul test sanguinL’étude montre que les patients atteints de diabète de type 2 ont un risque accru de développer la NASHLille (France), Cambridge (Massachusetts, États-Unis), le 10 novembre 2019 – GENFIT (Nasdaq et Euronext: GNFT), société biopharmaceutique de phase avancée focalisée sur la découverte et le développement de solutions thérapeutiques et diagnostiques innovantes dans le domaine des maladies...